Novel plasmon-coupled Ag/Ag2O nano-particles to downregulate β-catenin pathway in triple negative breast cancer

Abstract We prepared novel plasmon-coupled silver (Ag) and silver oxide (Ag 2 O) nanoparticles using green synthesis and a magnetic stirrer device from lemon juice. Firstly, we prepared six Ag samples from green tea and lemon juice, characterized by XRD, FTIR, UV, and HRTEM. We selected just two samples to apply to MDA-MB-231 cells. The samples entered the cell through endocytosis, showed moderate cytotoxicity and ROS levels, caused cell growth arrest at the G2M phase, exhibited higher inhibition of Cyclin D1, and induced early apoptosis. β-Catenin is an abundant protein in triple-negative breast cancer TNBC. Both samples showed inhibition of the β-catenin proteins pathway. Plasmon-coupled nanoparticles effectively inhibited β-catenin, physically capturing β-catenin and its pathway proteins, mimicking the action of a degradation protein complex due to their geometric properties. The prepared materials could be considered a promising treatment for TNBC that has not responded to chemotherapy and radiotherapy. As they have low toxicity to normal cells; this paves the way for new material designs without strict size limitations.

Authors

Institutions

Publication Details

Journal
Cancer Nanotechnology
Published
2024-10-23
DOI
https://doi.org/10.1186/s12645-024-00292-0
Citations
2
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.37

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel plasmon-coupled Ag/Ag2O nano-particles to downregulate β-catenin pathway in triple negative breast cancer

Ahmed A. G. El‐Shahawy, Saad M. El‐Gendy, S.I. El‐Dek, Ahmed Mohamed
2 citations
Cancer Nanotechnology
Nanoplatforms for cancer theranostics
0.37
article

Novel plasmon-coupled Ag/Ag2O nano-particles to downregulate β-catenin pathway in triple negative breast cancer

Ahmed A. G. El‐Shahawy, Saad M. El‐Gendy, S.I. El‐Dek, Ahmed Mohamed
article en
2 citations

Abstract

Abstract We prepared novel plasmon-coupled silver (Ag) and silver oxide (Ag 2 O) nanoparticles using green synthesis and a magnetic stirrer device from lemon juice. Firstly, we prepared six Ag samples from green tea and lemon juice, characterized by XRD, FTIR, UV, and HRTEM. We selected just two samples to apply to MDA-MB-231 cells. The samples entered the cell through endocytosis, showed moderate cytotoxicity and ROS levels, caused cell growth arrest at the G2M phase, exhibited higher inhibition of Cyclin D1, and induced early apoptosis. β-Catenin is an abundant protein in triple-negative breast cancer TNBC. Both samples showed inhibition of the β-catenin proteins pathway. Plasmon-coupled nanoparticles effectively inhibited β-catenin, physically capturing β-catenin and its pathway proteins, mimicking the action of a degradation protein complex due to their geometric properties. The prepared materials could be considered a promising treatment for TNBC that has not responded to chemotherapy and radiotherapy. As they have low toxicity to normal cells; this paves the way for new material designs without strict size limitations.

Cancer NanotechnologyVol. 15(1)
Beni-Suef University (EG), Cairo University (EG)
Beni-Suef University, Science and Technology Development Fund
Good health and well-being
Openalex Percentile: Top 43%
Nanoplatforms for cancer theranostics
0.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Novel plasmon-coupled Ag/Ag2O nano-particles to downregulate β-catenin pathway in triple negative breast cancer — Ahmed A. G. El‐Shahawy, Saad M. El‐Gendy, et al. · Cancer Nanotechnology (2024) | TGRS Research Map | TGRS